Vanguard Group Inc Moderna, Inc. Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 40,226,214 shares of MRNA stock, worth $1.65 Billion. This represents 0.05% of its overall portfolio holdings.
Number of Shares
40,226,214
Previous 39,562,796
1.68%
Holding current value
$1.65 Billion
Previous $4.7 Billion
42.78%
% of portfolio
0.05%
Previous 0.09%
Shares
15 transactions
Others Institutions Holding MRNA
# of Institutions
952Shares Held
241MCall Options Held
10.6MPut Options Held
18.7M-
Baillie Gifford & CO42.5MShares$1.75 Billion2.17% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.05 Billion0.07% of portfolio
-
State Street Corp Boston, MA16.8MShares$693 Million0.05% of portfolio
-
Theleme Partners LLP London, X07.23MShares$297 Million28.47% of portfolio
-
Geode Capital Management, LLC Boston, MA7.07MShares$291 Million0.04% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $16.1B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...